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ABSTRACT
The aim of this paper is to perform a review of the research literature on the issue of endometrial cancer and 
the impact on the immune system of the two major surgical methods - open and minimally invasive.
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Corpus uteri cancer is the most frequently oc-
curring carcinoma among females in Europe. Fur-
thermore, it is among the ten most common cancers 
in general.
Despite the progress of the diagnostic and ther-
apeutic methods, the number of cancer cases and 
mortality is on the rise worldwide. This increase is 
related  both to the higher diagnostic capacities and 
to the increased frequency of triggering pathogenetic 
mechanisms associated with modern lifestyles: over-
weight, hypokinesia, metabolic and hormonal disor-
ders. (1) According to data from the Bulgarian Na-
tional Cancer Registry, corpus uteri cancer accounts 
for 8.3% share of all malignant diseases among fe-
males and ranks third in terms of incidence after 
breast and colon cancer (Fig. 1), (2,3).
The reasons for its development are various. 
One of the leading among them is obesity.
Back in the 1980s. of the past century Gambrell 
et al. (1983), and Davis et al. (1981) demonstrated that 
Figure 1. Percentage of distribution of the most frequent 
malignancies among females in Bulgaria, 2012 (4,5).
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nuclei, and various numbers of mitoses. These signs 
are united under the name „pleomorphism“ (11).
The clinical manifestation of the disease is 
characterized by:
 ❖ Genital bleeding that occurs against a back-
ground of endometrial hyperplasia - an ear-
ly symptom such as vaginal bleeding within or 
beyond the menstrual cycle;
 ❖ Pain in the lower abdomen - occurring much 
later, when the tumor process is advanced;
 ❖ Fluor - late symptom associated with necrotic 
changes in the tumor.
As with any other disease, corpus uteri carcino-
ma affects the immune system.
It is known that it consists of two separate sub-
divisions: non-specific or innate immune system and 
adaptive, or specific immune system. Each subdivi-
sion has cellular and  humoral elements allowing the 
immune system to defend the body against foreign 
cancer and pathogens.
Surgical intervention related to a major surgical 
trauma causes development of „hormonal stress re-
sponse“, which is achieved by the systematic release 
of cortisol, catecholamines, angiotensin, vasopressin, 
insulin, etc., and cytokine production as well during 
the acute-phase response. In the human body, there 
is a sensitive balance between pro- and anti-inflam-
matory cytokines. As a result of the surgical trauma, 
the lowered immune response quickly entails the de-
velopment of the so-called Syndrome of Systemic 
Inflammatory Response (SIRS) and multiple organ 
failure (MOF).
This raises the question of choosing the most 
sparing surgical technique whereby the frequency of 
these dangerous complications can be prevented or 
reduced.
The past decade has seen the publication of 
many studies regarding the impact of the two tradi-
tional surgical methods: open and minimally inva-
sive on various functional immune parameters. 
Based on these, it may be inferred that big sur-
gical operations lead to a period of cell-mediated im-
munosuppression, which may exert an influence on 
the patient’s recovery. 
Most researchers share the common view that 
laparotomy causes increased secretion of cytokines 
and respiratory mediatory burst. 
patients whose weight is 50 kg over their normal lim-
it are exposed to a higher risk of developing endome-
trial carcinoma (6,7).
The source of elevated circulation levels of es-
trogen in patients with obesity is the aromatization 
of androstenedione to estrone, which takes place in 
the peripheral adipose tissue (8).
Other major factors for  the development of en-
dometrial carcinoma include diabetes mellitus, fam-
ily history, high-fat diet, etc. (9,10).
Corpus uteri carcinomas fall into two main 
categories:
Type I – endometroide type, hormone depen-
dent. It is preceded by endometrial hyperplasia, with 
slow development and good prognosis;
Type II – clear-cell, serous, etc.; non-hormone 
dependent, evolving against a background of atro-
phic endometrium; aggressive in its progressing, for-
mating early metastases, with poor prognosis.










Е. Squamous cell carcinoma
F. Clear cell carcinoma
G. Combined cell carcinoma
Н. Mucinous carcinoma
Among these, adenocarcinoma is the most fre-
quent histological type.
It is distinguished by considerable distortion of 
the glands’ arrangements, their number is growing, 
and various grades of atypia are observed. The over-
all picture is characterized by a decrease in stroma, 
neoplastic growth of the glands, which  are located 
„back to back“.
Cell proliferation leads to stratification, papil-
lary formation and eventually, to gland obliteration. 
The individual cellular changes include varying de-
grees of immaturity and dedifferentiation of cells, 
hyperchromatosis, aniso-chromatosis, monstrous 
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In minimally invasive surgical methods, the ex-
tent to which the CO2-induced pneumoperitoneum 
leads to suppression of the function of macrophages 
is certain. It is also clear that open surgery is related 
to higher levels of CRP and IL-6 as compared to the 
minimally invasive surgical methods (12).
The pro-inflammatory cascade activation after 
infection, after surgery or trauma, is important for 
the development of subsequent immune dysfunction, 
susceptibility to multiple organ failure and sepsis.
Although there are conflicting data between 
the studies in relation to certain immune parame-
ters, there is a general agreement in respect to oth-
er variables.
It is demonstrated that additional factors, such 
as anesthesia and preoperative blood transfusion, 
pain and hyperglycemia may further distort the  im-
mune performance.
A study of Scholl et al. conducted in 2012 de-
scribes the manner in which „surgical stress“ and in-
flammatory reactions affect the immune system and 
how it changes the sensitivity of the patient to these 
adverse events (13).
A study conducted by Bobocea et al. demon-
strates that big conventional surgical operations give 
rise to a significant change in immunological re-
sponse, which is especially important in cancer pa-
tients, as the postoperative suppression is associated 
with septic complications, a lower survival rate, tu-
mor spread and metastasis formation.
Clinical studies have shown that laparoscopic 
surgery preserves in a better way the immunological 
function of patients. Postoperative plasma concen-
trations of C-reactive protein (CRP) , IL-10, IL-6 and 
TNF-α have been demonstrated as being lower after 
minimally invasive operations (14).
The author comes to the conclusion that im-
mune function is influenced by the degree of surgi-
cal trauma. In minimally invasive surgery, reduced 
acute-phase response is observed as compared to 
open procedures and it leads to better preservation of 
the cellular immune mechanisms.
According to Kehlet et al. (1999), the peri-oper-
ative immune system response is determined by the 
severity of the surgical trauma (15).
El Azab et al. (2002), Kawamura et al. (2006), 
and Cheng (2005) report higher levels of pro-inflam-
matory cytokines IL-8 and IL-6 as well as of the anti-
inflammatory cytokine IL-10 (16,17,18).
Kehlet (1999) explains this with the smaller tis-
sue trauma (15).
The research team of Sheeran (1977) describes a 
significant increase in plasma concentrations of IL-6 
only between the second and the fourth post-surgery 
hour (19).
Other interesting results can be found in the 
study of Schneemilch (2004), which registers intra - 
and postoperative high levels of IL-10 (20).
In 2014, Maas et al. (2014) publish a randomized 
trial comparing the conventional and minimally in-
vasive surgery. They establish the existence of a sig-
nificant difference between the two studied groups 
of patients in favor of the minimally invasive operat-
ing technique, which results in better levels of leuko-
cytes and IL-8 (21).
In regard to CRP and IL-6 no significant differ-
ences between the two groups have been observed. 
They find that the poor results obtained with the 
conventional access are due to postoperative respira-
tory infections observed in the postoperative period.
Another randomized study of surgical stress 
and postoperative immune function after conven-
tional and minimally invasive surgery is that of Veen-
hof et al. (2010), who summarize that in minimally 
invasive surgical access, a better short-term preser-
vation of the immune function is achieved. The in-
creased level of IL-6 is lower than that in open surgi-
cal access (4.6 vs. 10.8; p = 0.003) (22).
No differences have been observed between 
the two groups in regard to the number of leuko-
cytes, monocytes, CRP, and IL-8 in the postopera-
tive period.
A large-scale study on the impact of robot-as-
sisted and conventional surgery on the immune sys-
tem in females with endometrial carcinoma is con-
ducted by Dimitrov et al., and its results convincing-
ly prove the immune-sparing role of robotic surgery 
in these patients (12).
CONCLUSION
Even though the prognosis of endometrium 
carcinoma is good in most of the cases, its diagnost-
ing in later stages is associated with high morbidity 
and  mortality level.
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Therefore, prevention, early diagnosis and min-
imization of surgical intervention comprise the key 
to successful treatment, reducing the severity of the 
disease progression, and ultimately contribute to a 
lesser moral, social and economic cost of the disease.
An increasingly greater number of gynecolo-
gists, in addition to the usual clinical and histolog-
ical studies, extend the information about the neo-
plastic process so as to include biochemical and im-
munological markers - tumor markers, hormones, 
lymphocyte populations, cytokines, lesion-inflam-
matory process markers, etc.
The comprehensive assessment of the immuno-
logical level and the abnormal intracellular metabo-
lism are the basis for individual differences, neoplas-
tic aggression, influence of anesthesia and surgery, 
postoperative recovery and prognosis.
In the field of gynecological oncology, there is 
an increasing theoretical and practical interest in 
the effects of different surgical methods with respect 
to the immune system as a prognostic factor for the 
treatment effect on the neoplastic process.
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